JAGUAR HEALTH INC (JAGX) Stock Cash Flow
NASDAQ:JAGX - Nasdaq - US47010C8055 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -38.20M | -41.87M | -49.08M | -52.60M | -33.81M | |||
| Depreciation Amortization | 1.92M | 2.01M | 1.98M | 1.72M | 1.73M | |||
| Income Taxes - Deferred | N/A | N/A | N/A | N/A | N/A | |||
| Change In Working Capital | -4.90M | -11.10M | -4.43M | 2.27M | -3.47M | |||
| Interest Paid | 26.00K | 35.00K | 23.00K | 28.00K | 757.00K | |||
| Other non cash items | 12.17M | 17.71M | 18.42M | 13.64M | 20.27M | |||
| OPERATING CASH FLOW | -29.01M | -33.24M | -33.10M | -34.97M | -15.28M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | 0.00 | -1.68M | -6.00K | -7.00K | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | N/A | 0.00 | -1.68M | -6.00K | -7.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -244.00K | -100.00K | 3.88M | 9.05M | 12.74M | |||
| Stock Issued/Repurchased | 40.16M | 33.95M | 20.46M | 35.62M | 7.76M | |||
| Other Financing Activity | -897.00K | 380.00K | -1.16M | -731.00K | -1.01M | |||
| FINANCING CASH FLOW | 39.02M | 34.23M | 23.18M | 43.94M | 19.49M | |||
| Exchange Rate Effect | 46.00K | 15.00K | 16.00K | N/A | N/A | |||
| CHANGE IN CASH | 10.04M | 1000.00K | -11.58M | 8.96M | 4.21M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -29.01M | -33.24M | -33.10M | -34.97M | -15.28M | |||
| Capital Expenditure | N/A | 0.00 | -1.68M | -6.00K | -7.00K | |||
| FREE CASH FLOW | -29.02M | -33.24M | -34.78M | -34.98M | -15.29M | |||
All data in USD